annual accounts payable:
$3.64B+$373.00M(+11.42%)Summary
- As of today (June 22, 2025), AZN annual accounts payable is $3.64 billion, with the most recent change of +$373.00 million (+11.42%) on December 31, 2024.
- During the last 3 years, AZN annual accounts payable has risen by +$816.00 million (+28.90%).
- AZN annual accounts payable is now -59.44% below its all-time high of $8.97 billion, reached on December 31, 2011.
Performance
AZN Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$22.54B(NaN%)Summary
- As of today (June 22, 2025), AZN quarterly accounts payable is $22.54 billion
- Over the past year, AZN quarterly accounts payable has increased by +$2.85 billion (+14.44%).
- AZN quarterly accounts payable is now at all-time high.
Performance
AZN quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AZN Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.4% | +14.4% |
| 3 y3 years | +28.9% | +26.2% |
| 5 y5 years | +105.2% | +78.5% |
AZN Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.8% | at high | +784.1% |
| 5 y | 5-year | at high | +105.2% | at high | +859.3% |
| alltime | all time | -59.4% | +631.3% | at high | +3503.0% |
AZN Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $22.54B(+4.0%) |
| Dec 2024 | $3.64B(+11.4%) | - |
| Sep 2024 | - | $21.68B(+6.0%) |
| Jun 2024 | - | $20.46B(+3.9%) |
| Mar 2024 | - | $19.70B(-4.1%) |
| Dec 2023 | $3.27B(+28.1%) | - |
| Sep 2023 | - | $20.54B(+4.1%) |
| Jun 2023 | - | $19.74B(+2.7%) |
| Mar 2023 | - | $19.21B(+653.3%) |
| Dec 2022 | $2.55B(-9.7%) | $2.55B(-85.6%) |
| Sep 2022 | - | $17.69B(-0.7%) |
| Jun 2022 | - | $17.82B(-0.2%) |
| Mar 2022 | - | $17.86B(+532.6%) |
| Dec 2021 | $2.82B(+20.2%) | $2.82B(-84.9%) |
| Sep 2021 | - | $18.66B(+5.3%) |
| Jun 2021 | - | $17.73B(+2.1%) |
| Mar 2021 | - | $17.37B(+639.1%) |
| Dec 2020 | $2.35B(+32.5%) | $2.35B(-82.5%) |
| Sep 2020 | - | $13.41B(+11.5%) |
| Jun 2020 | - | $12.03B(-4.8%) |
| Mar 2020 | - | $12.63B(+612.1%) |
| Dec 2019 | $1.77B(+3.1%) | $1.77B(-85.9%) |
| Sep 2019 | - | $12.54B(-0.8%) |
| Jun 2019 | - | $12.64B(-3.5%) |
| Mar 2019 | - | $13.10B(+661.7%) |
| Dec 2018 | $1.72B(-24.7%) | $1.72B(-84.4%) |
| Sep 2018 | - | $10.99B(+0.7%) |
| Jun 2018 | - | $10.91B(-4.9%) |
| Mar 2018 | - | $11.48B(+402.5%) |
| Dec 2017 | $2.29B(+36.0%) | $2.29B(-78.9%) |
| Sep 2017 | - | $10.83B(+7.5%) |
| Jun 2017 | - | $10.07B(+1.7%) |
| Mar 2017 | - | $9.90B(+489.2%) |
| Dec 2016 | $1.68B(-51.6%) | $1.68B(-83.1%) |
| Sep 2016 | - | $9.96B(-2.9%) |
| Jun 2016 | - | $10.26B(-8.2%) |
| Mar 2016 | - | $11.17B(+222.1%) |
| Dec 2015 | $3.47B(-0.7%) | $3.47B(-67.3%) |
| Sep 2015 | - | $10.59B(-0.6%) |
| Jun 2015 | - | $10.66B(+1.4%) |
| Mar 2015 | - | $10.51B(+201.0%) |
| Dec 2014 | $3.49B(+39.7%) | $3.49B(-65.6%) |
| Sep 2014 | - | $10.15B(-1.5%) |
| Jun 2014 | - | $10.30B(-3.0%) |
| Mar 2014 | - | $10.63B(+325.2%) |
| Dec 2013 | $2.50B(+2.0%) | $2.50B(-73.0%) |
| Sep 2013 | - | $9.24B(-4.1%) |
| Jun 2013 | - | $9.64B(+1.9%) |
| Mar 2013 | - | $9.46B(+286.5%) |
| Dec 2012 | $2.45B | $2.45B(-71.6%) |
| Sep 2012 | - | $8.63B(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $8.97B(+0.3%) |
| Mar 2012 | - | $8.95B(-0.3%) |
| Dec 2011 | $8.97B(+297.7%) | $8.97B(+11.8%) |
| Sep 2011 | - | $8.03B(-5.7%) |
| Jun 2011 | - | $8.51B(-1.8%) |
| Mar 2011 | - | $8.67B(+284.2%) |
| Dec 2010 | $2.26B(-15.1%) | $2.26B(-71.0%) |
| Sep 2010 | - | $7.80B(+5.9%) |
| Jun 2010 | - | $7.36B(-13.5%) |
| Mar 2010 | - | $8.51B(+220.1%) |
| Dec 2009 | $2.66B(-63.0%) | $2.66B(-64.0%) |
| Sep 2009 | - | $7.38B(+0.3%) |
| Jun 2009 | - | $7.37B(+3.0%) |
| Mar 2009 | - | $7.15B(-0.4%) |
| Dec 2008 | $7.18B(+105.3%) | $7.18B(+3.4%) |
| Sep 2008 | - | $6.94B(-6.3%) |
| Jun 2008 | - | $7.41B(+3.0%) |
| Mar 2008 | - | $7.19B(+105.7%) |
| Dec 2007 | $3.50B(+0.4%) | $3.50B(-47.3%) |
| Sep 2007 | - | $6.63B(-5.6%) |
| Jun 2007 | - | $7.03B(+1.6%) |
| Mar 2007 | - | $6.91B(+98.5%) |
| Dec 2006 | $3.48B(-36.3%) | $3.48B(-39.8%) |
| Sep 2006 | - | $5.78B(-12.1%) |
| Jun 2006 | - | $6.57B(+3.8%) |
| Mar 2006 | - | $6.33B(+15.9%) |
| Dec 2005 | $5.47B(+74.9%) | $5.47B(+1.1%) |
| Sep 2005 | - | $5.40B(-1.7%) |
| Jun 2005 | - | $5.50B(+0.5%) |
| Mar 2005 | - | $5.47B(+74.9%) |
| Dec 2004 | $3.13B(+1.3%) | $3.13B(-52.6%) |
| Sep 2004 | - | $6.59B(-14.1%) |
| Mar 2004 | - | $7.67B(+148.7%) |
| Dec 2003 | $3.09B(-2.7%) | $3.09B(-2.7%) |
| Dec 2002 | $3.17B(+33.0%) | $3.17B(-54.0%) |
| Sep 2002 | - | $6.90B(+189.3%) |
| Dec 2001 | $2.38B(-20.6%) | $2.38B(-62.8%) |
| Sep 2001 | - | $6.40B(+113.1%) |
| Dec 2000 | $3.01B(+86.2%) | $3.01B(-58.4%) |
| Sep 2000 | - | $7.22B(+347.5%) |
| Dec 1999 | $1.61B(+84.6%) | $1.61B(-40.7%) |
| Jun 1998 | - | $2.72B(+211.5%) |
| Dec 1997 | $874.50M(+6.6%) | $874.50M(+6.6%) |
| Dec 1996 | $820.29M(-0.2%) | $820.29M(-0.2%) |
| Dec 1995 | $822.05M(+3.9%) | $822.05M(-67.9%) |
| Jun 1995 | - | $2.56B(+224.1%) |
| Dec 1994 | $791.08M(+26.4%) | $791.08M(+26.4%) |
| Dec 1993 | $625.70M(+17.9%) | $625.70M |
| Dec 1992 | $530.84M(+6.7%) | - |
| Dec 1991 | $497.74M(-65.4%) | - |
| Dec 1990 | $1.44B | - |
FAQ
- What is AstraZeneca annual accounts payable?
- What is the all time high annual accounts payable for AstraZeneca?
- What is AstraZeneca annual accounts payable year-on-year change?
- What is AstraZeneca quarterly accounts payable?
- What is the all time high quarterly accounts payable for AstraZeneca?
- What is AstraZeneca quarterly accounts payable year-on-year change?
What is AstraZeneca annual accounts payable?
The current annual accounts payable of AZN is $3.64B
What is the all time high annual accounts payable for AstraZeneca?
AstraZeneca all-time high annual accounts payable is $8.97B
What is AstraZeneca annual accounts payable year-on-year change?
Over the past year, AZN annual accounts payable has changed by +$373.00M (+11.42%)
What is AstraZeneca quarterly accounts payable?
The current quarterly accounts payable of AZN is $22.54B
What is the all time high quarterly accounts payable for AstraZeneca?
AstraZeneca all-time high quarterly accounts payable is $22.54B
What is AstraZeneca quarterly accounts payable year-on-year change?
Over the past year, AZN quarterly accounts payable has changed by +$2.85B (+14.44%)